SY
So-Young International Inc.NASDAQHealthcare$2.87+4.36%ClosedMarket Cap: $377.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.63
P/S
1.68
EV/EBITDA
-8.91
DCF Value
$-0.91
FCF Yield
0.0%
Div Yield
0.9%
Margins & Returns
Gross Margin
47.8%
Operating Margin
-17.5%
Net Margin
-15.9%
ROE
-14.3%
ROA
-9.1%
ROIC
-13.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $454.4M | 44.4% | $-101.8M | $-107.3M | $-0.81 | — |
| FY 2025 | $1.48B | 47.8% | $-259.2M | $-235.7M | $-1.78 | $0.03 |
| Q3 2025 | $386.7M | 47.3% | $-72.7M | $-64.3M | $-0.49 | — |
| Q2 2025 | $378.7M | 51.3% | $-47.1M | $-36.0M | $-0.28 | $0.03 |
| Q1 2025 | $297.3M | 49.1% | $-43.4M | $-33.1M | $-0.25 | — |
| Q4 2024 | $369.2M | 58.5% | $-599.1M | $-607.6M | $-4.55 | — |
| FY 2024 | $1.47B | 61.3% | $-624.5M | $-589.5M | $-4.39 | $0.06 |
| Q3 2024 | $371.8M | 61.8% | $4.7M | $20.3M | $0.15 | — |
| Q2 2024 | $407.4M | 61.9% | $6.7M | $18.9M | $0.14 | $0.06 |
| Q1 2024 | $318.3M | 63.1% | $-36.8M | $-21.2M | $-0.16 | — |
| Q4 2023 | $390.6M | 64.8% | $-4.9M | $17.5M | $0.13 | — |
| FY 2023 | $1.50B | 63.7% | $-61.0M | $21.3M | $0.16 | — |